Silence Therapeutics (SLN) Earnings
|
Expand Research on SLN
| Next EPS Date | 5/14/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/14/24 | Q124 | N/A | -$0.11 | N/A | N/A | $13.95M | N/A | N/A | N/A | ||
| 3/13/24 | Q423 | N/A | -$0.08 | N/A | N/A | $8.88M | N/A | N/A | N/A | ||
| 11/14/23 | Q323 | -$0.07 | -$0.17 | +$0.10 | $2.8M | $2.94M | N/A |  | | Details | |
| 9/13/23 | Q223 | N/A | -$0.17 | N/A | N/A | $3.82M | N/A | N/A | N/A | ||
| 5/15/23 | Q123 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/15/23 | Q422 | N/A | -$0.01 | N/A | N/A | $20.37M | N/A | N/A | N/A | ||
3/17/22  |
 |
Q422 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 11/15/22 | Q322 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A |
